These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16287086)

  • 1. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer.
    Wiedswang G; Borgen E; Schirmer C; Kåresen R; Kvalheim G; Nesland JM; Naume B
    Int J Cancer; 2006 Apr; 118(8):2013-9. PubMed ID: 16287086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
    Schindlbeck C; Andergassen U; Hofmann S; Jückstock J; Jeschke U; Sommer H; Friese K; Janni W; Rack B
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1055-62. PubMed ID: 23525580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of disseminated tumour cells from the bone marrow of early stage breast cancer patients - results from a large single-centre analysis.
    Hartkopf AD; Taran FA; Wallwiener M; Hahn M; Becker S; Solomayer EF; Brucker SY; Fehm TN; Wallwiener D
    Eur J Cancer; 2014 Oct; 50(15):2550-9. PubMed ID: 25096167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy.
    Solá M; Margelí M; Castellá E; Cirauqui B; Mariscal A; Rull M; Julian JF; Luna M; Vallejo V; Fraile M
    Breast; 2013 Oct; 22(5):908-13. PubMed ID: 23683695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
    Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
    Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell dissemination to the bone marrow and blood is associated with poor outcome in patients with metastatic breast cancer.
    Hartkopf AD; Stefanescu D; Wallwiener M; Hahn M; Becker S; Solomayer EF; Fehm TN; Brucker SY; Taran FA
    Breast Cancer Res Treat; 2014 Sep; 147(2):345-51. PubMed ID: 25151295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.
    Hinz S; Hendricks A; Wittig A; Schafmayer C; Tepel J; Kalthoff H; Becker T; Röder C
    BMC Cancer; 2017 Jan; 17(1):53. PubMed ID: 28086834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
    Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival.
    Mathiesen RR; Borgen E; Renolen A; Løkkevik E; Nesland JM; Anker G; Ostenstad B; Lundgren S; Risberg T; Mjaaland I; Kvalheim G; Lønning PE; Naume B
    Breast Cancer Res; 2012 Aug; 14(4):R117. PubMed ID: 22889108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated tumor cells and enhanced level of some cytokines in bone marrow and peripheral blood of breast cancer patients as predictive factors of tumor progression.
    Semesiuk NI; Zhylchuk A; Bezdenezhnykh N; Lykhova A; Vorontsova AL; Zhylchuk VE; Kudryavets YI
    Exp Oncol; 2013 Dec; 35(4):295-302. PubMed ID: 24382441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
    Fehm T; Banys M; Rack B; Jäger B; Hartkopf A; Taran FA; Janni W
    Int J Cancer; 2014 Feb; 134(4):925-31. PubMed ID: 23921989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
    Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
    Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of disseminated tumor cells in the bone marrow of patients with operable primary breast cancer: a long-term follow-up study.
    Domschke C; Diel IJ; Englert S; Kalteisen S; Mayer L; Rom J; Heil J; Sohn C; Schuetz F
    Ann Surg Oncol; 2013 Jun; 20(6):1865-71. PubMed ID: 23263703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer.
    Vashist YK; Effenberger KE; Vettorazzi E; Riethdorf S; Yekebas EF; Izbicki JR; Pantel K
    Ann Surg; 2012 Jun; 255(6):1105-12. PubMed ID: 22580852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
    Naume B; Synnestvedt M; Falk RS; Wiedswang G; Weyde K; Risberg T; Kersten C; Mjaaland I; Vindi L; Sommer HH; Sætersdal AB; Rypdal MC; Bendigtsen Schirmer C; Wist EA; Borgen E
    J Clin Oncol; 2014 Dec; 32(34):3848-57. PubMed ID: 25366688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: Biological relevance of disseminated tumor cells in cancer patients.
    Riethdorf S; Wikman H; Pantel K
    Int J Cancer; 2008 Nov; 123(9):1991-2006. PubMed ID: 18712708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.